Bionime (TPE:4737) Common Stock: NT$673 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4737 Bionime Corp TPE:4737
64 GF Score
Price NT$62.20
GF Value NT$58.78
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bionime Common Stock?

Bionime TPE:4737 -2.20% 64 Common Stock is NT$673 Mil as of Dec. 2025. GuruFocus rates TPE:4737 with a GF Score™ of 64/100 and a GF Value™ of NT$58.78 (Fairly Valued). The stock has 7 warning signs investors should review.

Bionime's quarterly common stock increased from Jun. 2025 (NT$673 Mil) to Sep. 2025 (NT$675 Mil) but then declined from Sep. 2025 (NT$675 Mil) to Dec. 2025 (NT$673 Mil).

Bionime's annual common stock declined from Dec. 2023 (NT$615 Mil) to Dec. 2024 (NT$612 Mil) but then increased from Dec. 2024 (NT$612 Mil) to Dec. 2025 (NT$673 Mil).

Bionime Common Stock Historical Data

* Premium members only.

The historical data trend for Bionime's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionime Common Stock Chart

Bionime Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 637.97 610.28 614.75 612.18 673.32

Bionime Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 612.18 611.52 673.28 674.88 673.32
TPE:4737
64GF Score
Bionime Corp TPE:4737
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionime Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of NT$673 Mil mean?
Bionime (TPE:4737) has a Common Stock of NT$673 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bionime and its competitors.
Is Bionime's Common Stock too high?
Bionime's current Common Stock is NT$673 Mil. Overall, Bionime has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bionime's Common Stock compare to ISRG and BDX?
Bionime's Common Stock of NT$673 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bionime and its competitors. Bionime's current Common Stock is NT$673 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionime stock overvalued right now?
Based on GuruFocus' analysis, Bionime (TPE:4737) is currently considered Fairly Valued. The stock's GF Value™ is NT$58.78, compared to a current price of NT$62.20 — trading 5.8% above its estimated fair value. The current Common Stock is NT$673 Mil. Bionime's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Bionime (TPE:4737), the current Common Stock is NT$673 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bionime (TPE:4737) Overvalued in 2026?

Based on GuruFocus' analysis, Bionime stock appears to be overvalued. The current stock price of NT$62.20 is trading 5.8% above its estimated GF Value™ of NT$58.78. GuruFocus considers Bionime to be Fairly Valued.

Key valuation signals for TPE:4737:

  • Common Stock: NT$673 Mil
  • GF Value™: NT$58.78 vs. price of NT$62.20 (5.8% above fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the TPE:4737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bionime Business Description

Address No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's revenue is derived from the sale of blood glucose meters and test strips to domestic and foreign clients. Geographically, it operates in Algeria, China, Switzerland, the United States, Belarus, Egypt, the United Arab Emirates, and other countries, of which it derives the maximum revenue from Algeria.
64GF Score

Get the complete analysis for TPE:4737

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$62.20
Price
NT$58.78
GF Value